The current study is a first report on the phylogenetic and the medicinal properties of an Algerian mushroom Cyclocybe cylindracea strain TMES42. Different extracts were obtained from sequential liquid-liquid extraction using three solvents of increasing polarity (chloroform, ethyl acetate and butanol). Antioxidant potential was evaluated using different methods (DPPH, ABTS, FRAP, and phenanthroline assays). The phenolic composition of acetate-ethyl-extract (AcEt-Ext) was characterized under LC-ESI-MS-MS analysis, and the antiproliferative effect was determined against the breast-maligned cell line MCF-7. Results demonstrated that the studied mushroom has a promising cytotoxic activity. Its AcEt-Ext fraction showed significant antioxidant activities as well as high phenolic acid and total phenolic content compared with other fractions. This fraction induced breast malignant cell cytotoxicity, exhibiting an IC50 value of 59.84 ± 4.06 μg/ml, and demonstrated a significant selectivity index; these findings suggest that C. cylindracea could be regarded as a promising natural therapeutic agent.

Molecular Phylogenetic and Chemistry Characterization, and In Vitro Evaluation of Antioxidant and Cytotoxicity Potential of Cyclocybe cylindracea strain TMES42 (Agaricomycetes) from Algeria

Massimiliano, PERDUCA;
2025-01-01

Abstract

The current study is a first report on the phylogenetic and the medicinal properties of an Algerian mushroom Cyclocybe cylindracea strain TMES42. Different extracts were obtained from sequential liquid-liquid extraction using three solvents of increasing polarity (chloroform, ethyl acetate and butanol). Antioxidant potential was evaluated using different methods (DPPH, ABTS, FRAP, and phenanthroline assays). The phenolic composition of acetate-ethyl-extract (AcEt-Ext) was characterized under LC-ESI-MS-MS analysis, and the antiproliferative effect was determined against the breast-maligned cell line MCF-7. Results demonstrated that the studied mushroom has a promising cytotoxic activity. Its AcEt-Ext fraction showed significant antioxidant activities as well as high phenolic acid and total phenolic content compared with other fractions. This fraction induced breast malignant cell cytotoxicity, exhibiting an IC50 value of 59.84 ± 4.06 μg/ml, and demonstrated a significant selectivity index; these findings suggest that C. cylindracea could be regarded as a promising natural therapeutic agent.
2025
Cyclocybe cylindracea strain MEST42, medicinal mushrooms, bioactive compounds, antioxidant, LC-ESI-MS/MS, cytotoxic activity
File in questo prodotto:
File Dimensione Formato  
a71 Cyclocybe cylindracea IJMM 2025.pdf

solo utenti autorizzati

Descrizione: Molecular, Phylogenetic, and Chemistry Characterization and In Vitro Evaluation of the Antioxidant and Cytotoxicity Potential of Cyclocybe cylindracea Strain TMES42 (Agaricomycetes) from Algeria
Tipologia: Documento in Post-print
Licenza: Accesso ristretto
Dimensione 4.87 MB
Formato Adobe PDF
4.87 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1164110
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact